Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
25
%Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPNet Sales3,643¥ millionYear on year +25.0%Progress 25.3%
Operating profit784¥ millionYear on year +24.6%Progress 25.3%
Ordinary income778¥ millionYear on year +20.6%Progress 25.1%
Net income attributable to owners of the parent623¥ millionYear on year +61.0%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥54.43
Financial position at period-end
Total assets18,227¥ million
of which net assets 11,456 ¥ millionEquity ratio 62.2%vs. prior year-end -1.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥14,400 million (YoY +16.8%)
Operating profit¥3,100 million (YoY +15.6%)
Ordinary income¥3,100 million (YoY +16.3%)
Profit attributable to owners of the parent¥3,100 million (YoY +5.0%)
Annual Dividend Forecast¥38.00 → ¥40.00（5.3%）
Factors Behind Changes in Business Performance
An increase in the number of prescriptions submitted online, an increase in the value of pharmaceutical distribution through dispensing pharmacies and medical institutions, an increase in the number of system users, and the creation of added value by strengthening the integration of data accumulated across each business
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 2 / Company name 株式会社テクノネットワーク, 株式会社ケイング / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsAt a meeting of the Board of Directors held on 23 July 2026, the company resolved to make 株式会社blankpad a wholly owned subsidiary through the acquisition of its shares. The business combination date is 1 August 2026, the percentage of voting rights acquired is 100%, and the acquisition consideration is ¥5 in cash.
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Office relocation expenses ¥4,897 thousand
Depreciation and amortization¥375,173 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End11,459,482 shares
Treasury Shares at Period-End69,700 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥3,643 million (YoY +25.0%) |
| Operating profit | ¥784 million (YoY +24.6%) |
| Ordinary income | ¥778 million (YoY +20.6%) |
| Profit attributable to owners of the parent | ¥623 million (YoY +61.0%) |
| Net income per share | ¥54.43 |
| Equity ratio | End of the current fiscal period 62.2% / End of previous period 63.7% |
| Total assets | ¥18,227 million |
| Net assets | ¥11,456 million |
| Full-year earnings forecast | Net Sales ¥14,400 million (YoY +16.8%) / Operating profit ¥3,100 million (YoY +15.6%) / Ordinary income ¥3,100 million (YoY +16.3%) / Profit attributable to owners of the parent ¥3,100 million (YoY +5.0%) |
| Annual Dividend Forecast | ¥38.00 → ¥40.00（5.3%） |
| Depreciation and amortization | ¥375,173 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Office relocation expenses ¥4,897 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 2 / Company name 株式会社テクノネットワーク, 株式会社ケイング / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | At a meeting of the Board of Directors held on 23 July 2026, the company resolved to make 株式会社blankpad a wholly owned subsidiary through the acquisition of its shares. The business combination date is 1 August 2026, the percentage of voting rights acquired is 100%, and the acquisition consideration is ¥5 in cash. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 11,459,482 shares |
| Treasury Shares at Period-End | 69,700 shares |
| Factors Behind Changes in Business Performance | An increase in the number of prescriptions submitted online, an increase in the value of pharmaceutical distribution through dispensing pharmacies and medical institutions, an increase in the number of system users, and the creation of added value by strengthening the integration of data accumulated across each business |
Items this document does not state (13)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company said it worked to increase the number of prescriptions submitted online, the value of pharmaceutical distribution through dispensing pharmacies and medical institutions, and the number of system users, while also seeking to create added value by strengthening the integration of data accumulated across its businesses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.